Barriers to HIV Cure

被引:21
|
作者
Stein, J. [1 ]
Bonsmann, M. Storcksdieck Genannt [1 ]
Streeck, H. [1 ,2 ]
机构
[1] Univ Duisburg Essen, Univ Hosp Essen, Inst HIV Res, Essen, Germany
[2] Henry M Jackson Fdn, US Mil HIV Res Program, Rockville, MD USA
关键词
cellular barriers; HIV; immunological barriers; SIMIAN IMMUNODEFICIENCY VIRUS; T FOLLICULAR HELPER; ACTIVE ANTIRETROVIRAL THERAPY; CENTRAL-NERVOUS-SYSTEM; INFECTED PATIENTS; POSTEXPOSURE PROPHYLAXIS; CONTROLLED-TRIAL; VIRAL RESERVOIR; IMMUNE FUNCTION; CELL DEPLETION;
D O I
10.1111/tan.12867
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Since the beginning of the epidemic, more than 70 million people have been infected with human immunodeficiency virus (HIV) and about 38 million have died from acquired immune deficiency syndrome (AIDS)-related illnesses. While the discovery of highly active antiretroviral therapy (HAART) in the mid 90' s has saved millions of lives, a complete eradication of HIV is still not possible as HIV can persist for decades in a small reservoir of latently infected cells. Once reactivated, these latently infected cells can actively produce viral particles. Recent studies suggest that several sanctuaries exist within infected individuals where HIV can remain undetected by the immune system. These cellular, anatomical and microanatomical viral reservoirs represent a major obstacle for the eradication of HIV. Here we review recent findings on potential sanctuaries of HIV and address potential avenues to overcome these immunological barriers.
引用
收藏
页码:155 / 163
页数:9
相关论文
共 50 条
  • [1] Barriers to a cure for HIV in women
    Gianella, Sara
    Tsibris, Athe
    Barr, Liz
    Godfrey, Catherine
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [2] Barriers for HIV Cure: The Latent Reservoir
    Castro-Gonzalez, Sergio
    Colomer-Lluch, Marta
    Serra-Moreno, Ruth
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 (09) : 739 - 759
  • [3] Barriers and strategies to achieve a cure for HIV
    Pitman, Matthew C.
    Lau, Jillian S. Y.
    McMahon, James H.
    Lewin, Sharon R.
    LANCET HIV, 2018, 5 (06): : E317 - E328
  • [4] HIV Persistence on Antiretroviral Therapy and Barriers to a Cure
    Sung, Julia Marsh
    Margolis, David M.
    HIV VACCINES AND CURE: THE PATH TOWARDS FINDING AN EFFECTIVE CURE AND VACCINE, 2018, 1075 : 165 - 185
  • [5] Editorial: Strategies and barriers for hepatitis B cure: implications for HIV
    Revill, Peter A.
    Lewin, Sharon R.
    CURRENT OPINION IN HIV AND AIDS, 2020, 15 (03) : 151 - 156
  • [6] Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs
    Katlama, Christine
    Deeks, Steven G.
    Autran, Brigitte
    Martinez-Picado, Javier
    van Lunzen, Jan
    Rouzioux, Christine
    Miller, Michael
    Vella, Stefano
    Schmitz, Joern E.
    Ahlers, Jeffrey
    Richman, Douglas D.
    Sekaly, Rafick P.
    LANCET, 2013, 381 (9883): : 2109 - 2117
  • [7] Viral Persistence in the Gut-Associated Lymphoid Tissue and Barriers to HIV Cure
    Cossarini, Francesca
    Aberg, Judith A.
    Chen, Benjamin K.
    Mehandru, Saurabh
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2024, 40 (01) : 54 - 65
  • [8] An ordeal that does not heal: understanding barriers to a cure for HIV-1 infection
    Lichterfeld, Mathias
    Gao, Ce
    Yu, Xu G.
    TRENDS IN IMMUNOLOGY, 2022, 43 (08) : 608 - 616
  • [9] A cure for HIV?
    不详
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2010, 8 (01) : 61 - 61
  • [10] HIV Persistence on Antiretroviral Therapy and Barriers to a Cure (vol 1075, pg 165, 2018)
    Sung, Julia Marsh
    Margolis, David M.
    HIV VACCINES AND CURE: THE PATH TOWARDS FINDING AN EFFECTIVE CURE AND VACCINE, 2018, 1075 : E1 - E1